This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
9 Sep 2011

Pfizer Moves Cardiovascular & Endocrine Disease Research Unit to Massachusetts

Pfizer has moved its research unit for cardiovascular and endocrine disease from Groton to Cambridge, Massachusetts.

New York-based pharmaceutical giant Pfizer Inc. said Wednesday that it has moved its research unit for cardiovascular and endocrine disease from Groton to Cambridge, Massachusetts.

 

Pfizer said that the move completed this summer and that its neuroscience unit would follow next year. The announcement came as the company said it had signed a 10-year agreement with the Massachusetts Institute of Technology to move the two research units into a new 180,000-square-foot research headquarters in Cambridge's Kendall Square.

 

Pfizer said 400 to 450 researchers -- many currently working in Groton -- would eventually populate the new Cambridge site, which won't be ready for occupancy until late in 2013. The company added that scientists previously working in the Groton cardiovascular research unit were se

Related News